GEN Financial Management’s Amgen AMGN Stock Holding History

GEN Financial Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,502	Closed	-$652K	–	52
2024 Q4	$652K	Buy	+2,502	New	+$742K	0.42%	28

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GEN Financial Management's AMGN Position: Q1 2025 in Review

GEN Financial Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 2,502 shares — an estimated $652K sold.

GEN Financial Management first reported a position in AMGN in Q4 2024 and held it in 1 quarter. The position peaked at $652K in Q4 2024. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

GEN Financial Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
GEN Financial Management sold 2,502 Amgen shares in Q1 2025, an estimated $652K.
GEN Financial Management first reported a position in Amgen in Q4 2024 and held it in 1 quarter.
GEN Financial Management's Amgen position peaked at $652K in Q4 2024.
2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on GEN Financial Management's 13F filing for Q1 2025, filed 16 Apr 2025.